Chiba, M., Miyata, K., Okawa, H., Tanaka, Y., Ueda, K., Seimiya, H. and Takahashi, A.

YBX1 regulates satellite II RNA loading into small extracellular vesicles and promotes the senescent phenotype .
Int. J. Mol. Sci., 24, 16399 (2023)

https://www.mdpi.com/1422-0067/24/22/16399

Chen, M., Mashima, T., Oishi, T., Muramatsu, Y., Seto, Y., Takamatsu, M., Kawata, N., Morino, S., Nakamura, A., Inaba, S., Yuan, X., Maruyama, K., Suzuki, M., Sato, A., Yoshida, H., Jang, M. K., Mizutani, A., Takeuch, K., Yamaguchi, K., Shirai, F., Nagayama, S., Katayama, R. and Seimiya, H.

APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.
British Jouornal of Cancer, in press (2023)

Kondo, N., Utsumi, T., Shimizu, Y., Takemoto, A., Oh-Hara, T., Uchibori, K., Subat-Motoshi, S., Ninomiya, H., Takeuchi, K., Nishio, M., Miyazaki, Y. and Katayama, R.

MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF.
JCI insight, in press (2023)

Qian, J., Zhou, X., Tanaka, K. and Takahashi, A.

Alteration in the chromatin landscape during the DNA damage response: Continuous rotation of the gear driving cellular senescence and aging.
DNA repair, 131, 103572 (2023)

Yoshida, T., Kumagai, T., Toyozawa, R., Katayama, R., Nishio, M., Seto, T., Goto, K., Yamamoto, N., Ohe, Y., Kudou, K., Asato, T., Zhang, P. and Nakagawa, K.

Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trial.
Cancer Sci., 114, 3698-3707 (2023)

more